3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Genitourinary
11
Gastrointestinal
10
Breast
8
Other hematologic neoplasm
5
Lymphoid
5
Gynecologic
5
CNS
4
Head & Neck
3
Dermatologic
3
Thoracic
2
Endocrine
2
Classical hematology
2
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
NET
1
Conditions
Neuroendocrine Tumors
130
Gastro-enteropancreatic neuroendocrine tumor
16
Pancreatic Neoplasms
14
Neoplasms
12
Stomach Neoplasms
8
Carcinoma, Neuroendocrine
8
Carcinoid Tumor
8
Prostatic Neoplasms
7
Lung Neoplasms
7
Carcinoma, Hepatocellular
7
Breast Neoplasms
7
Thyroid Neoplasms
6
Melanoma
6
Esophageal Neoplasms
6
Colonic Neoplasms
6
Rectal Neoplasms
5
Pheochromocytoma
5
Neoplasm Metastasis
5
Gastrointestinal Stromal Tumors
5
Carcinoma
5
Adenoma, Islet Cell
5
Adenocarcinoma
5
Testicular Neoplasms
4
Skin Neoplasms
4
Serotonin Syndrome
4
Sarcoma
4
Paraganglioma
4
Liver Neoplasms
4
Kidney Neoplasms
4
Head and Neck Neoplasms
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Genetic Predisposition to Disease
×
NET
×
Clear all
NCT04788927
2023-04-07
PPGL-Pred
Rigshospitalet, Denmark
Not yet recruiting
400 enrolled